Posted on August 10th, 2012
Bridgewater Associates LP, the hedge fund founded by Ray Dalio, has filed their Q2 2012 13f filing.
Summary for 06/30/2012 13F Filing
| Market Value: |
$6,725,851,182 |
| Prior Market Value: |
$6,429,521,608 |
| New Purchases: |
56 stocks |
| Additional Purchases: |
75 stocks |
| Sold out of: |
122 stocks |
| Reduced holdings in: |
62 stocks |
| Concentration % of Top 10 Holdings: |
86.87% |
13F Holdings Summary
Posted on August 10th, 2012
Some interesting 13F’s are starting to stream in as we get closer to this quarter’s filing deadline.
Point Lobos Capital, an employee owned hedge fund founded by Ryan Schaper, has filed their Q2 2012 13f filing.
Summary for 06/30/2012 13F Filing
| Market Value: |
$145,600,186 |
| Prior Market Value: |
$105,753,384 |
| New Purchases: |
stocks |
| Additional Purchases: |
5 stocks |
| Sold out of: |
5 stocks |
| Reduced holdings in: |
3 stocks |
| Concentration % of Top 10 Holdings: |
107.24% |
13F Holdings Summary
View All Holdings
Posted on August 7th, 2012
Pennant Capital Management, LLC, a hedge fund founded by Alan Fournier, filed a new 13G disclosing ownership of 9,308,172 shares of TEX as of July 27th. This gives Pennant a 8.49% stake in the company and is an increase of 1,684,802 shares over what they reported on their March 31, 2012 13F.
From Yahoo! Finance, Terex Corporation manufactures capital goods machinery products worldwide.
Ownership History in TEX
| Reported via |
Date |
Name |
Ticker |
Shares |
% of Portfolio |
| 13F |
2010-09-30 |
Terex Corp. |
TEX |
975,400 |
0.65 |
| 13F |
2010-12-31 |
Terex Corp. |
TEX |
2,700,300 |
2.20 |
| 13F |
2011-03-31 |
Terex Corp. |
TEX |
3,285,300 |
2.75 |
| 13F |
2011-06-30 |
Terex Corp. |
TEX |
4,815,300 |
2.94 |
| SC 13G |
2011-08-08 |
Terex Corp. |
TEX |
7,345,300 |
N/A |
| 13F |
2011-09-30 |
Terex Corp. |
TEX |
8,305,300 |
2.10 |
| 13F |
2011-12-31 |
Terex Corp. |
TEX |
7,742,700 |
2.71 |
| SC 13G/A |
2012-02-14 |
Terex Corp. |
TEX |
7,742,700 |
N/A |
| 13F |
2012-03-31 |
Terex Corp. |
TEX |
7,623,370 |
3.88 |
| SC 13G/A |
2012-07-27 |
Terex Corp. |
TEX |
9,308,172 |
N/A |
Posted on July 30th, 2012
Glenview Capital Management, a privately held hedge fund run byLawrence Robbins , filed a new 13G disclosing ownership of 7,866,100 shares of ROVI as of July 18th. This gives Glenview a 7.09% stake in the company and is an increase of 7,155,100 shares over what they reported on their March 31st 13F.
From Yahoo! Finance, Rovi Corporation provides digital entertainment technology solutions for the discovery and management of entertainment content.
Ownership History in ROVI
| Reported via |
Date |
Name |
Ticker |
Shares |
% of Portfolio |
| 13F |
2003-03-31 |
Rovi Corporation |
ROVI |
350,000 |
0.78 |
| 13F |
2008-06-30 |
Rovi Corporation |
ROVI |
8,426,059 |
1.25 |
| 13F |
2008-09-30 |
Rovi Corporation |
ROVI |
9,341,139 |
1.80 |
| 13F |
2008-12-31 |
Rovi Corporation |
ROVI |
5,949,033 |
2.61 |
| 13F |
2009-03-31 |
Rovi Corporation |
ROVI |
2,689,134 |
1.81 |
| 13F |
2009-06-30 |
Rovi Corporation |
ROVI |
2,789,134 |
1.67 |
| 13F |
2012-03-31 |
Rovi Corporation |
ROVI |
711,000 |
0.42 |
| SC 13G |
2012-07-18 |
Rovi Corporation |
ROVI |
7,866,100 |
N/A |
Posted on July 30th, 2012
Adage Capital Partners, a Boston hedge fund founded by Robert Atchinson, filed a new 13G disclosing ownership of 8,461,868 shares of AMLN as of July 20th. This gives Adage a 5.2% stake in the company and is an increase of 8,450,000 shares over what they reported on their March 31st 13F.
From Yahoo! Finance, Amylin Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drug candidates for the treatment of diabetes, obesity, and other diseases.
Ownership History in AMLN
| Reported via |
Date |
Name |
Ticker |
Shares |
% of Portfolio |
| 13F |
2004-12-31 |
Amylin Pharmaceuticals, Inc. |
AMLN |
150,000 |
0.03 |
| 13F |
2006-03-31 |
Amylin Pharmaceuticals, Inc. |
AMLN |
150,000 |
0.06 |
| 13F |
2007-12-31 |
Amylin Pharmaceuticals, Inc. |
AMLN |
400,000 |
0.08 |
| 13F |
2008-12-31 |
Amylin Pharmaceuticals, Inc. |
AMLN |
300,000 |
0.03 |
| 13F |
2010-03-31 |
Amylin Pharmaceuticals, Inc. |
AMLN |
500,000 |
0.05 |
| 13F |
2010-06-30 |
Amylin Pharmaceuticals, Inc. |
AMLN |
1,400,000 |
0.12 |
| 13F |
2010-09-30 |
Amylin Pharmaceuticals, Inc. |
AMLN |
850,000 |
0.08 |
| 13F |
2012-03-31 |
Amylin Pharmaceuticals, Inc. |
AMLN |
11,868 |
0.00 |
| SC 13G |
2012-07-20 |
Amylin Pharmaceuticals, Inc. |
AMLN |
8,461,868 |
N/A |